GW-6604 is an ALK5 inhibitor with an IC 50 value of 140 nM for inhibiting its autophosphorylation, and can be used in the study of liver fibrosis. In Vitro GW-6604 (0-10 μM, ) inhibits TGF-β-induced PAI-1 transcription and secretion in HepG2 cells with an IC 50 value of 500 nM, effectively blocking the Smad-dependent response. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo GW-6604(p.o., 25-80 mg/kg, twice a day, 3 weeks) dependently inhibits hepatic COL IA1 overexpression in an acute DMN model in SD rats, reducing its expression by 80%. Normal liver weight was maintained, liver fibrosis was effectively reduced and matrix degeneration was increased . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
GW-6604
CAS number：452342-37-9 molecular formula：C19H14N4
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | GW6604;GW 6604 | SCHEMBL154508 | UNII-273G6SN31H | Pyridine, 2-phenyl-4-(3-(2-pyridinyl)-1H-pyrazol-4-yl)- | 2-Phenyl-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridine | 2-phenyl-4-(5-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | Q27254160 | BDBM50184881 | EX-A6727 | ||
| CAS number | 452342-37-9 | molecular formula | C19H14N4 |
| molecular weight | 298.34 g/mol | Exact mass | ≥98% |
| PSA | 54.500 Ų | logp | 3.1 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
